AbbVie Inc.

ABBV · Healthcare

$259.99

Markedsværdi: 459.43B USDUdbytteafkast: +2.70%
AdvancedEr det et godt tidspunkt at købe AbbVie Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire Inc.5. sep. 2026, 00.30

Atopic Dermatitis Drugs Market Set to Reach USD 33.42 Billion by 2035, at a CAGR of 7.70% - SNS Insider

The global atopic dermatitis drugs market is projected to grow from USD 15.92 billion in 2025 to USD 33.42 billion by 2035, driven by increased adoption of biologic therapies, JAK inhibitors, and novel treatments. North America leads with 36% market share, while Asia-Pacific shows the fastest growth. Biologics dominate with 42% market share, though high costs and JAK inhibitor safety warnings present challenges.

The Motley Fool4. sep. 2026, 18.30

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie has successfully diversified beyond its blockbuster Humira with strong immunology drugs (Skyrizi and Rinvoq), while Pfizer is leveraging its cash position to build oncology and GLP-1 pipelines. Despite AbbVie's stronger growth trajectory, Pfizer offers better valuation metrics with lower P/E and P/S ratios, making it the preferred choice for long-term value investors willing to wait for new product launches.

Zacks Investment Research4. sep. 2026, 18.15

DELL Stock Hits 52-Week High: Does it Have More Room to Run?

The article covers various investment themes and sectors including robotics and AI adoption, pharmaceuticals driven by aging populations, airline industry opportunities, and oil/natural gas earnings growth. It also discusses employment data showing Leisure & Hospitality leading job growth, and provides analysis of major tech companies like Amazon, AbbVie, and Alibaba facing different growth drivers and challenges.

Zacks Investment Research4. sep. 2026, 14.07

McDonald's Trades at 19.15X P/E: Is This a Discounted Opportunity?

The article covers various market developments including August employment data expectations (55,000 new jobs, 4.2% unemployment rate), sector performance with Leisure & Hospitality leading job growth, and analysis of multiple stock sectors including biotech, gold stocks, airlines, and pharmaceuticals. It also discusses Space ETFs and various investment opportunities across different market segments.

Zacks Investment Research4. sep. 2026, 13.30

Brokers Suggest Investing in AppFolio (APPF): Read This Before Placing a Bet

The article covers various market developments including August employment data expectations (55,000 new jobs, 4.2% unemployment rate), sector performance with Leisure & Hospitality leading job growth, and analysis of multiple investment opportunities across sectors including oil/gas, biotech, gold stocks, and airlines. Market commentary includes discussion of S&P 500 earnings projections for 2026 Q3 showing +23.0% growth.